Abstract
Cryptococcus is an encapsulated yeast that causes fungal meningitis, most commonly in HIV patients, with high mortality rates. Thus, the study of new treatment options is relevant. Antifungal activity of organoselenium compounds attributed to their pro-oxidative effect in fungal cells has been shown given that few data regarding its anti-Cryptococcus activity are available, this in vitro study was conducted with 40 clinical isolates of Cryptococcus neoformans. Diphenyl diselenide (DD) alone, and its interaction with amphotericin B or fluconazole, was tested by microdilution and checkerboard assays. All Cryptococcus neoformans were inhibited by DD in concentrations ≤ 32 μg/mL, and fungicidal concentrations were ≤ 64 μg/mL. Advantageous interaction between fluconazole occurred in 40% of the isolates, respectively. This study contributes with data of DD alone and in combination with classical drugs of choice for cryptococcosis treatment. Further studies focused on DD antifungal mechanism of action, and in vivo experiments are necessary.
Data availability
Not applicable.
Code availability
Not applicable.
References
World Health Organization (2018). Guidelines for the diagnosis, prevention, and management of cryptococcal disease in HIV-infected adults, adolescents and children.https://www.who.int/hiv/pub/guidelines/cryptococcal-disease/en/Accessed 16 Apr 2021
Bongomin F, Oladele RO, Gago S, Moore CB, Richardson MD (2018) A systematic review of fluconazole resistance in clinical isolates of Cryptococcus species. Mycoses 61:290–297. https://doi.org/10.1111/myc.12747
Robbins N, Wright GD, Cowen LE (2016). Antifungal drugs: the current armamentarium and development of new agents. Microbiol Spectr. 4:https://doi.org/10.1128/microbiolspec.FUNK-0002-2016
Benelli JL, Poester VR, Munhoz LS, et al (2021). Ebselen and diphenyl diselenide against fungal pathogens: a systematic review [published online ahead of print, 2021 Jan 9]. Med Mycol. https://doi.org/10.1093/mmy/myaa115
Melo AM, Poester VR, Trapaga M et al (2020) Diphenyl diselenide and its interaction with antifungals against Aspergillus spp. Med Mycol. https://doi.org/10.1093/mmy/myaa072
da Silva LB, Bock D, Klafke GB et al (2020) Cryptococcosis in HIV-AIDS patients from Southern Brazil: still a major problem. J Mycol Med 30:101044. https://doi.org/10.1016/j.mycmed.2020.101044
Paulmier C (1986) Selenium reagents and intermediates in organic synthesis. Seleno-organic functional groups, 1st edn. Pergamon, Oxford, pp 25–57
Clinical and Laboratory Standards Institute (2017) Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard-fourth edition. CLSI document M27- A4.Wayne, PA. https://clsi.org/standards/products/microbiology/documents/m27/Accessed 16 Apr 2021
Eliopoulos GM, Moellering RC (1991) Antimicrobial combinations. In: Lorian V (ed) Antibiotics in laboratory medicine, 3rd edn. Williams & Wilkins Co., Baltimore, MD, pp 432–492
Odds FC (2003) Synergy, antagonism, and what the chequerboard puts between them. J Antimicrob Chemother 52:1. https://doi.org/10.1093/jac/dkg301
Nogueira CW, Rocha JBT (2010) Diphenyl diselenide a janus-faced molecule. J Braz Chem Soc 21:2055–2071. https://doi.org/10.1590/S0103-50532010001100006
De Bem AF, Portella RDL, Farina M et al (2007) Low toxicity of diphenyl diselenide in rabbits: a long-term study. Basic Clin Pharmacol Toxicol 101:47–55. https://doi.org/10.1111/j.1742-7843.2007.00073.x
Prigol M, Brüning CA, Martini F, Nogueira CW (2012) Comparative excretion and tissue distribution of selenium in mice and rats following treatment with diphenyl diselenide. Biol Trace Elem Res 150:272–277. https://doi.org/10.1007/s12011-012-9464-z
Rossato L, Loreto ES, Venturini TP et al (2019) In vitro combination between antifungals and diphenyl diselenide against Cryptococcus species. Mycoses 62:508–512. https://doi.org/10.1111/myc.12905
Grossman NT, Casadevall A (2017) Physiological differences in Cryptococcus neoformans strains in vitro versus in vivo and their effects on antifungal susceptibility. Antimicrob Agents Chemother 61:e02108-e2116. https://doi.org/10.1128/AAC.02108-16
Peng CA, Gaertner AAE, Henriquez SA, Fang D, Colon-Reyes RJ, Brumaghim JL et al (2018) Fluconazole induces ROS in Cryptococcus neoformans and contributes to DNA damage in vitro. PLoS ONE 13:e0208471. https://doi.org/10.1371/journal.pone.0208471
Dbouk NH, Covington MB, Nguyen K, Chandrasekaran S (2019) Increase of reactive oxygen species contributes to growth inhibition by fluconazole in Cryptococcus neoformans. BMC Microbiol 19(1):243. https://doi.org/10.1186/s12866-019-1606-4
Ding C, Festa RA, Chen YL et al (2013) Cryptococcus neoformans copper detoxification machinery is critical for fungal virulence. Cell Host Microbe 13:265–276. https://doi.org/10.1016/j.chom.2013.02.002
Lee IR, Lui EY, Chow EW, Arras SD, Morrow CA, Fraser JA (2013) Reactive oxygen species homeostasis and virulence of the fungal pathogen Cryptococcus neoformans requires an intact proline catabolism pathway. Genetics 194:421–433. https://doi.org/10.1534/genetics.113.150326
Acknowledgements
The authors are grateful to the Health Science Post-graduation Program, of College of Medicine from Federal University of Rio Grande, and to Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES, Brazil).
Author information
Authors and Affiliations
Contributions
Jéssica Louise Benell: study design, development and methodology, collection of data, data analysis and interpretation, and writing all of the manuscript.
Vanice Rodrigues Poester: Development and methodology, collection of data, and data analysis and interpretation.
Lívia Silveira Munhoz: Development and methodology, collection of data, and data analysis and interpretation.
Gabriel Baracy Klafke: Development and methodology, collection of data, and data analysis and interpretation.
David A. Stevens: Writing all of the manuscript and manuscript revision.
Melissa Orzechowski Xavier: Study design, development and methodology, collection of data, data analysis and interpretation, writing all of the manuscript, and manuscript revision.
Corresponding author
Ethics declarations
Ethics approval
Not applicable.
Consent to participate
Not applicable.
Consent for publication
The authors consented to the publication.
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Responsible Editor: Rosana Puccia
Partial data from this study was published as an abstract at the “12º Congresso Paulista de Infectologia.”
Rights and permissions
About this article
Cite this article
Benelli, J.L., Poester, V.R., Munhoz, L.S. et al. In vitro anti-Cryptococcus activity of diphenyl diselenide alone and in combination with amphotericin B and fluconazole . Braz J Microbiol 52, 1719–1723 (2021). https://doi.org/10.1007/s42770-021-00552-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s42770-021-00552-w